197 related articles for article (PubMed ID: 19631303)
1. Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD.
Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C
Bone; 2009 Nov; 45(5):833-42. PubMed ID: 19631303
[TBL] [Abstract][Full Text] [Related]
2. Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.
Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C
Bone; 2007 Mar; 40(3):723-9. PubMed ID: 17081815
[TBL] [Abstract][Full Text] [Related]
3. Role of gastrointestinal hormones in postprandial reduction of bone resorption.
Henriksen DB; Alexandersen P; Bjarnason NH; Vilsbøll T; Hartmann B; Henriksen EE; Byrjalsen I; Krarup T; Holst JJ; Christiansen C
J Bone Miner Res; 2003 Dec; 18(12):2180-9. PubMed ID: 14672353
[TBL] [Abstract][Full Text] [Related]
4. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.
Zhang G; Qin L; Shi Y
J Bone Miner Res; 2007 Jul; 22(7):1072-9. PubMed ID: 17419678
[TBL] [Abstract][Full Text] [Related]
5. Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome.
Gottschalck IB; Jeppesen PB; Hartmann B; Holst JJ; Henriksen DB
Scand J Gastroenterol; 2008; 43(11):1304-10. PubMed ID: 18609184
[TBL] [Abstract][Full Text] [Related]
6. Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women.
Ruckle J; Jacobs M; Kramer W; Pearsall AE; Kumar R; Underwood KW; Seehra J; Yang Y; Condon CH; Sherman ML
J Bone Miner Res; 2009 Apr; 24(4):744-52. PubMed ID: 19049340
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
8. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women.
Harkness LS; Fiedler K; Sehgal AR; Oravec D; Lerner E
J Womens Health (Larchmt); 2004 Nov; 13(9):1000-7. PubMed ID: 15665657
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
[TBL] [Abstract][Full Text] [Related]
10. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
Choi HJ; Im JA; Kim SH
Maturitas; 2008 Jun; 60(2):170-6. PubMed ID: 18572334
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.
Recker RR; Benson CT; Matsumoto T; Bolognese MA; Robins DA; Alam J; Chiang AY; Hu L; Krege JH; Sowa H; Mitlak BH; Myers SL
J Bone Miner Res; 2015 Feb; 30(2):216-24. PubMed ID: 25196993
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial.
DeLuca HF; Bedale W; Binkley N; Gallagher JC; Bolognese M; Peacock M; Aloia J; Clagett-Dame M; Plum L
J Bone Miner Res; 2011 Mar; 26(3):538-45. PubMed ID: 20890933
[TBL] [Abstract][Full Text] [Related]
13. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody.
Padhi D; Jang G; Stouch B; Fang L; Posvar E
J Bone Miner Res; 2011 Jan; 26(1):19-26. PubMed ID: 20593411
[TBL] [Abstract][Full Text] [Related]
14. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
[TBL] [Abstract][Full Text] [Related]
15. Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate.
Holst JJ; Hartmann B; Gottschalck IB; Jeppesen PB; Miholic J; Henriksen DB
Scand J Gastroenterol; 2007 Jul; 42(7):814-20. PubMed ID: 17558904
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular neridronate in postmenopausal women with low bone mineral density.
Adami S; Gatti D; Bertoldo F; Sartori L; Di Munno O; Filipponi P; Marcocci C; Frediani B; Palummeri E; Fiore CE; Costi D; Rossini M
Calcif Tissue Int; 2008 Nov; 83(5):301-7. PubMed ID: 18946626
[TBL] [Abstract][Full Text] [Related]
17. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
Sánchez-Guerrero J; Fragoso-Loyo HE; Neuwelt CM; Wallace DJ; Ginzler EM; Sherrer YR; McIlwain HH; Freeman PG; Aranow C; Petri MA; Deodhar AA; Blanton E; Manzi S; Kavanaugh A; Lisse JR; Ramsey-Goldman R; McKay JD; Kivitz AJ; Mease PJ; Winkler AE; Kahl LE; Lee AH; Furie RA; Strand CV; Lou L; Ahmed M; Quarles B; Schwartz KE
J Rheumatol; 2008 Aug; 35(8):1567-75. PubMed ID: 18634158
[TBL] [Abstract][Full Text] [Related]
18. Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.
García-Pérez MA; Moreno-Mercer J; Tarín JJ; Cano A
Gynecol Endocrinol; 2006 Apr; 22(4):179-84. PubMed ID: 16723303
[TBL] [Abstract][Full Text] [Related]
19. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.
Hwang JS; Chen JF; Yang TS; Wu DJ; Tsai KS; Ho C; Wu CH; Su SL; Wang CJ; Tu ST
Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436
[TBL] [Abstract][Full Text] [Related]
20. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
